Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 48.10
-2.00 (-3.99%)
Jul 14, 2026, 1:24 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 2.05 billion as of July 14, 2026. Its market cap has increased by 26.74% in one year.
Market Cap
2.05B
Enterprise Value
1.61B
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.10
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 2.05B, an increase of 38.42%. That is a compound annual growth rate of 6.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 2.05B | 48.91% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlycoNex Incorporation | 2.84B |
| Syngen Biotech | 2.38B |
| Taiwan Bio Therapeutics | 2.28B |
| Sunny Pharmtech | 2.18B |
| HeXun Biosciences | 2.16B |
| Sunhawk Vision Biotech | 2.10B |
| G&E Herbal Biotechnology | 2.06B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.96B |